Latest Stories
FreeGuest Editorial
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full directory of our coverage is available here.
Janet Dancey, MD, FRCPC
Scientific director, Canadian Cancer Clinical Trials Network; Professor, Department of Oncology, Queen's University
